Category: Funding Roundup
Medical device company ViewRay announces a $17.4 million funding round, offering equity and Series D-2 preferred stock.
ViewRay Inc. has $2.4 million to go to reach its goal for a $17.4 million funding round
Seven investors are in on the offering, and $15 million had been sold at the time the company disclosed the funding round May 8, according to a regulatory filing.
Medical device company Thermedical adds $5 million to its Series A round for its soft tissue ablation technology.
Thermedical said it raised $5 million in a Series A2 round for the soft tissue ablation technology it's developed.
The Waltham, Mass.-based medical device company said the round, led by chairman Samuel Maslak and Karl Johannsmeier, takes its total outside investment to $7 million.
Medical device industry newcomer Sony Corp. joins Medtronic and Abbott in backing Israeli medtech portfolio company Rainbow Medical with a $10 million investment.
Technology giant Sony Corp. (TYO:6758) invested $10 million into Israel-based Rainbow Medical, a medical device portfolio company that has drawn other big players in the medtech industry.
CardioFocus raises $11 million for its HeartLight endoscopic ablation system in a round of debt financing from Oxford Finance and Silicon Valley Bank.
CardioFocus added $11 million to its coffers in a round of debt financing from Oxford Finance and Silicon Valley Bank as it commercializes its HeartLight endoscopic ablation system overseas and winds up enrollment in a pivotal U.S. trial.
CardioFocus CRO Renny Clark said the funds will help the company prepare for its submission to the FDA for the HeartLight device, which combines an endoscope and a laser ablation device, according to a press release.
Spinal devices maker InVivo Therapeutics expects to raise $10.4 million from a call for early exercise of warrants issued in 2010.
Massachusetts-based spinal devices maker InVivo Therapeutics (OTC:NVIV) announced an early call for exercise of warrants issued in 2010, expecting to raise $10.4 million.
Under the terms of the warrants, InVivo has the right to call for early exercise because NVIV shares have traded above $2.80 per share for 20 consecutive days, which occurred yesterday.
Medical device giant Boston Scientific leads a $9.7 million funding round for San Francisco-based cryoablation delivery technology maker Channel Medsystems.
Massachusetts-based medical device industry giant Boston Scientific (NYSE:BSX) led investment in the latest funding round for Channel Medsystems, a clinical-stage cryoablation delivery systems maker.
Total U.S. angel investments in 2012 grew 1.8% compared to 2011, but there were fewer funders in the market and they were much less interested in early-stage investments, according to the UNH Center for Venture Research.
Angel investors in the U.S. are making a comeback of sorts with total dollars still on the rise, but funders are shying away from early-stage investments and leaning toward expansion financing, according to a new report from the UNH Center for Venture Research.